Tinnitus. Tinnitus, unspecified ear
Conditions
Interventions
Intervention 1: intervention group: intratympanic injection of dexamethasone. In the first intervention group, which is a group of 40 people, they are subjected to intratympanic injection of dexametha
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients with tinnitus referred to Luqman educational-therapeutic-research center in 2024 Patients who cannot find a cause for their tinnitus Patients who include tinnitus and without concomitant disease such as rupture of the eardrum, a history of ear surgery, otosclerosis, Cerebellopontine angle tumor, ear trauma, disorders of internal systems such as hypothyroidism,Monocular hearing, diabetes and genetic disorders.
Exclusion criteria
Exclusion criteria: Patients who are excluded from the study for any reason during the research or follow-up is not possible. Patients who do not complete the full follow-up of the study (follow-up within 3 months). Patients who are excluded from the study due to possible complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus reduction in tinnitus handicap inventory (6 to 8 marks). Timepoint: In the period of the first 2 weeks after the injections and 1 month and 3 months later. First, before the start of the injections, at the beginning of the study, then at the end of 2 weeks, 1 month and 3 months. It is measured 4 times overall. Method of measurement: THI (tinnitus handicap inventory) questionnaire to measure tinnitus. Tinnitus handicap inventory is a 25-item questionnaire to determine the severity of tinnitus disability, which psychometrics have been proven in studies. The 25 items of the questionnaire are classified into three functional, emotional and catastrophic subscales. | — |
Secondary
| Measure | Time frame |
|---|---|
| Tympanic membrane perforation. Timepoint: In the first 2 weeks and 3 months later. It is checked twice in the study. Method of measurement: Examination under the microscope.;Hearing loss. Timepoint: In the first 2 weeks and 3 months later. It is checked twice in the study. Method of measurement: Audiogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhaem Khodabakhsh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed